VRPX

Virpax Pharmaceuticals, Inc. Common Stock

Delisted

VRPX was delisted on the 3rd of April, 2025.

15 hedge funds and large institutions have $121K invested in Virpax Pharmaceuticals, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$16K
2 +$5.59K
3 +$3.74K
4
UBS Group
UBS Group
Switzerland
+$2.12K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$1.37K

Top Sellers

1 -$234K
2 -$13.3K
3 -$50
Name Holding Trade Value Shares
Change
Change in
Stake
1
$32.3K
2
$21.2K
3
$20.2K
4
$16K
5
$10K
6
$5.59K
7
$4.87K
8
$3.74K
9
$2.12K
10
$2.02K
11
$1.37K
12
$768
13
$160
14
$149
15
$96
16
$21
17
$5
18